<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39290777</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2328-8957</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Open forum infectious diseases</Title><ISOAbbreviation>Open Forum Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Association of COVID-19 Vaccination With Risk of Medically Attended Postacute Sequelae of COVID-19 During the Ancestral, Alpha, Delta, and Omicron Variant Eras.</ArticleTitle><Pagination><StartPage>ofae495</StartPage><MedlinePgn>ofae495</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ofae495</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ofid/ofae495</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Uncertainty exists regarding the effectiveness of COVID-19 vaccine to prevent postacute sequelae of COVID-19 (PASC) following a breakthrough infection. While most studies based on symptom surveys found an association between preinfection vaccination status and PASC symptoms, studies of medically attended PASC are less common and have reported conflicting findings.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this retrospective cohort of patients with an initial SARS-CoV-2 infection who were continually empaneled for primary care in a large US health system, the electronic health record was queried for preinfection vaccination status, demographics, comorbidity index, and diagnosed conditions. Multivariable logistic regression was used to model the outcome of a medically attended PASC diagnosis within 6 months of SARS-CoV-2 infection. Likelihood ratio tests were used to assess the interaction between vaccination status and prevalent variant at the time of infection and between vaccination status and hospitalization for SARS-CoV-2 infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">During the observation period, 6.9% of patients experienced medically attended and diagnosed PASC. A diagnosis of PASC was associated with older age, female sex, hospitalization for the initial infection, and an increased severity-weighted comorbidity index and was inversely associated with infection during the Omicron period. No difference in the development of diagnosed PASC was observed between unvaccinated patients and those vaccinated with either 2 doses of an mRNA vaccine or &gt;2 doses.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">We found no association between vaccination status at the time of infection and development of medically diagnosed PASC. Vaccine remains an important measure to prevent SARS-CoV-2 infection and severity. Further research is needed to identify effective measures to prevent and treat PASC.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swift</LastName><ForeName>Melanie D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0002-5900-5573</Identifier><AffiliationInfo><Affiliation>Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breeher</LastName><ForeName>Laura E</ForeName><Initials>LE</Initials><Identifier Source="ORCID">0000-0002-6327-5162</Identifier><AffiliationInfo><Affiliation>Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dierkhising</LastName><ForeName>Ross</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5290-7021</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hickman</LastName><ForeName>Joel</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6673-6358</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Matthew G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roellinger</LastName><ForeName>Daniel L</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0001-8734-2393</Identifier><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virk</LastName><ForeName>Abinash</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3437-7159</Identifier><AffiliationInfo><Affiliation>Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Open Forum Infect Dis</MedlineTA><NlmUniqueID>101637045</NlmUniqueID><ISSNLinking>2328-8957</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 vaccine</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mRNA vaccine</Keyword><Keyword MajorTopicYN="N">postacute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>Potential conflicts of interest. M. D. S. discloses a current unpaid elected position on the American College of Occupational and Environmental Medicine Board of Directors. All other authors report no potential conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39290777</ArticleId><ArticleId IdType="pmc">PMC11406745</ArticleId><ArticleId IdType="doi">10.1093/ofid/ofae495</ArticleId><ArticleId IdType="pii">ofae495</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
US Centers for Disease Control and Prevention . Long COVID basics. Available at: https://www.cdc.gov/covid/long-term-effects/?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html. Accessed 16 August 2024.</Citation></Reference><Reference><Citation>Soriano &#xa0;JB, Murthy &#xa0;S, Marshall &#xa0;JC, Relan &#xa0;P, Diaz &#xa0;JV. A clinical case definition of post&#x2013;COVID-19 condition by a Delphi consensus. Lancet Infect Dis &#xa0;2022; 22:e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely &#xa0;EW, Brown &#xa0;LM, Fineberg &#xa0;HV; National Academies of Sciences, Engineering, and Medicine Committee on Examining the Working Definition for Long COVID . Long COVID defined. N Engl J Med. Published online 31 July 2024. doi:10.1056/NEJMsb2408466</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb2408466</ArticleId></ArticleIdList></Reference><Reference><Citation>Su &#xa0;S, Zhao &#xa0;Y, Zeng &#xa0;N, et al. &#xa0;Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update. Mol Psychiatry &#xa0;2023; 28:4056&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">37491461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kompaniyets &#xa0;L, Bull-Otterson &#xa0;L, Boehmer &#xa0;TK, et al. &#xa0;Post-COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years: United States, March 2020&#x2013;November 2021. MMWR-Morbid Mortal Wkly Rep &#xa0;2022; 71:993&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed &#xa0;I, Nauman &#xa0;A, Paul &#xa0;P, et al. &#xa0;The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum Vaccin Immunother &#xa0;2022; 18:2027160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862168</ArticleId><ArticleId IdType="pubmed">35113777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen &#xa0;CH, Moustsen-Helms &#xa0;IR, Rasmussen &#xa0;M, Soborg &#xa0;B, Ullum &#xa0;H, Valentiner-Branth &#xa0;P. Short-term effectiveness of the XBB.1.5 updated COVID-19 vaccine against hospitalisation in Denmark: a national cohort study. Lancet Infect Dis &#xa0;2024; 24:e73&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">38190834</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu &#xa0;N, Joyal-Desmarais &#xa0;K, Ribeiro &#xa0;PAB, et al. &#xa0;Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med &#xa0;2023; 11:439&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917454</ArticleId><ArticleId IdType="pubmed">36780914</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren &#xa0;O, Stehlik &#xa0;P, Clark &#xa0;J, Alcorn &#xa0;K, Glasziou &#xa0;P. Effect of COVID-19 vaccination on long COVID: systematic review. BMJ Med &#xa0;2023; 2:e000385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban &#xa0;F, Kulzhabayeva &#xa0;D, Rodrigues &#xa0;NB, et al. &#xa0;COVID-19 vaccination for the prevention and treatment of long COVID: a systematic review and meta-analysis. Brain Behav Immun &#xa0;2023; 111:211&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10067136</ArticleId><ArticleId IdType="pubmed">36990297</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe &#xa0;A, Iwagami &#xa0;M, Yasuhara &#xa0;J, Takagi &#xa0;H, Kuno &#xa0;T. Protective effect of COVID-19 vaccination against long COVID syndrome: a systematic review and meta-analysis. Vaccine &#xa0;2023; 41:1783&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly &#xa0;Z, Bowe &#xa0;B, Xie &#xa0;Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med &#xa0;2022; 28:1461&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Meza-Torres &#xa0;B, Delanerolle &#xa0;G, Okusi &#xa0;C, et al. &#xa0;Differences in clinical presentation with long COVID after community and hospital infection and associations with all-cause mortality: English Sentinel Network Database Study. JMIR Public Health Surveill &#xa0;2022; 8:e37668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384859</ArticleId><ArticleId IdType="pubmed">35605170</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet &#xa0;M, Dercon &#xa0;Q, Harrison &#xa0;PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun &#xa0;2022; 103:154&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis &#xa0;SN, Durieux &#xa0;JC, Mouchati &#xa0;C, Perez &#xa0;JA, McComsey &#xa0;GA. The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: a multicenter study from a large national health research network. Open Forum Infect Dis &#xa0;2022; 9:ofac228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Duerlund &#xa0;LS, Shakar &#xa0;S, Nielsen &#xa0;H, Bodilsen &#xa0;J. Positive predictive value of the ICD-10 diagnosis code for long-COVID. Clin Epidemiol &#xa0;2022; 14:141&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8843419</ArticleId><ArticleId IdType="pubmed">35177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Brannock &#xa0;MD, Chew &#xa0;RF, Preiss &#xa0;AJ, et al. &#xa0;Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat Commun &#xa0;2023; 14:2914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10201472</ArticleId><ArticleId IdType="pubmed">37217471</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannous &#xa0;J, Pan &#xa0;AP, Potter &#xa0;T, et al. &#xa0;Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population. BMJ Open &#xa0;2023; 13:e067611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10083521</ArticleId><ArticleId IdType="pubmed">37019490</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld &#xa0;MS, Peluso &#xa0;MJ, Peyser &#xa0;ND, et al. &#xa0;Factors associated with long COVID symptoms in an online cohort study. Open Forum Infect Dis. &#xa0;2023; 10: ofad047..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9945931</ArticleId><ArticleId IdType="pubmed">36846611</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg &#xa0;E, Han &#xa0;AX, Boyd &#xa0;A, et al. &#xa0;The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): a prospective cohort study. Vaccine &#xa0;2022; 40:4424&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie &#xa0;Y, Choi &#xa0;T, Al-Aly &#xa0;Z. Postacute sequelae of SARS-CoV-2 infection in the pre-Delta, Delta, and Omicron eras. N Engl J Med &#xa0;2024; 391:515&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">39018527</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini &#xa0;E, Levi &#xa0;R, Sarti &#xa0;R, et al. &#xa0;Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA &#xa0;2022; 328:676&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong &#xa0;MC, Huang &#xa0;J, Wong &#xa0;YY, et al. &#xa0;Epidemiology, symptomatology, and risk factors for long COVID symptoms: population-based, multicenter study. JMIR Public Health Surveill &#xa0;2023; 9:e42315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9994465</ArticleId><ArticleId IdType="pubmed">36645453</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff &#xa0;ER, Madlock-Brown &#xa0;C, Baratta &#xa0;JM, et al. &#xa0;Coding long COVID: characterizing a new disease through an ICD-10 lens. BMC Med &#xa0;2023; 21:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian &#xa0;A, Nirantharakumar &#xa0;K, Hughes &#xa0;S, et al. &#xa0;Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med &#xa0;2022; 28:1706&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>